FDA Clearance Tracker · K190318
VASOBand Vascular Compression Device
Last checked: Nov 19, 2026Latest source record: Mar 14, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Mar 14, 2019
Substantially Equivalent
Time to decision
29 days
Received Feb 13, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K190318
- Device name
- VASOBand Vascular Compression Device
- Applicant
- Vasoinnovations, Inc.
- Applicant location
- South Pasadena, CA
- Received
- Feb 13, 2019
- Decided
- Mar 14, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
- Third-party review
- Yes. An FDA-accredited third party reviewed this submission before FDA decided.
Device type
- Device type
- Clamp, Vascular (DXC)
- Device class
- Class II
- Regulation
- 21 CFR 870.4450
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DXC. The earliest in FDA's data is K761169, decided Dec 9, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K190318
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Vasoinnovations, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VASOBand Vascular Compression DeviceThird-party review510(k)
K203803 · Decided Jan 26, 2021 · 29 days after receipt
Device type: Clamp, Vascular (DXC) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.